Day 1 - Thursday, 13 September 2018
Topics
Meeting category
Date(s)
13 Sep 2018 - 15 Sep 2018
Location
Nairobi,
Kenya
Organizer
Platinum Level Support
Sponsor logos
Conference on Liver Disease in Africa (COLDA) 2018
Related Enduring Materials
Enduring Materials
Introduction to Viral Hepatitis and Liver Disease -
Mark Nelson, MA, MBBS, FRCP
Chairs
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Clinical spectrum of liver disease in Africa
Essential diagnostic tools for viral hepatitis (Not available)
Session 1: HCC and its management -
Mark Nelson, MA, MBBS, FRCP
Chair
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
The global challenge of viral hepatitis
Session 2: HIV-Hepatitis Coinfections -
Chairs
Edford Sinkala, BScHB, MBChB, MMed, PhD, FRCP
University Teaching Hospital, Lusaka, Zambia
The dangers of not treating-modelling the viral hepatitis epidemic in Africa (Not available)
Shevanthi Nayagam, MBBS
Imperial College, UK
Abstract driven presentations
Prevalence estimates of chronic hepatitis B virus infection: a comparative study of four sources and implications for burden assessment in sub-Saharan Africa
Nora Schmit #23
Epidemiology of hepatitis B and evaluation of vaccine efficacy in a census-based community serosurvey of Ndirande township in Blantyre, Malawi
Alexander Stockdale #33
Day 2 - Friday, 14 September 2018
Session 3: Hepatitis B -
Chairs
John Rwegasha, MBChB, M.MED, FRCP, MSc
Muhimbili National Hospital, Tanzania
Abstract driven presentations
Hepatitis B screening and prevention integration into ante-natal care and delivery services in an urban cohort in Mozambique
Natalia Tamayo Antabak #18
Population-based evaluation of hepatitis B markers and criteria for antiviral therapy in Lusaka Province, Zambia
Michael Vinikoor #17
Treatment of chronic hepatitis B in sub-Saharan Africa: 3-year results of a pilot program in Ethiopia
Asgeir Johannessen #19
Characterization of Hepatitis B Virus (HBV) Among Liver Patients in Kenya
Missiani Ochwoto #26
Session 4: Hepatitis C -
Chairs
How to treat HCV in a resource limited setting
Abstract driven presentations
Prevalence of HBV and HCV infections in screened people in Rwanda during WHD 2017 campaign
Jean Damascene Makuza #10
HCV diagnosis and direct-acting antiviral agents -based treatment for HIV/HCV co-infected patients in a primary care setting in Maputo, Mozambique
Natalia Tamayo Antabak #40
Ledipasvir/Sofosbuvir for Treatment of Hepatitis C Virus Infection in Rwanda: Results from the SHARED Trial
Emmanuel Musabeyezu #20
Session 5: Liver Disease in Special Population -
Chairs
Mark Sonderop, MD
-
Viral hepatitis in paediatrics (B and C)
Session 6: Future issues in liver disease in Africa -
Chairs
Francesco Marinucci
FIND, Italy
Shevanthi Nayagam, MBBS
Imperial College, UK
Alcoholic liver disease
Drug-induced liver disease: khat and other weeds
Fatty Liver disease
Day 3 - Saturday, 15th September 2018
Session 7: Other infectious liver disease -
Chairs
Mark Thursz, MRCP
Imperial College, St Mary's Hospital, UK
Abstract driven presentations
Point-of-care testing for hepatitis B virus infection in a community-based occupational health cohort in the Western Cape Province, South Africa
Nafiisah Chotun #43
Mother-to-child transmission of hepatitis B virus in Windhoek, Namibia: transmission dynamics and prevention (Not available)
Cynthia Tamandjou #39
Session 8: Clinical management of End-stage Liver Disease -
Chair
Gamal Esmat, MD
Cairo University, Egypt
Johannessen Asgeir, MD, PhD
Oslo University Hospital
Management of Hepatocellular Carcinoma in Africa
Abstract - driven presentations
Large-scale discovery and validation of blood and urinary discriminant metabolites as potential biomarkers for the diagnosis hepatocellular carcinoma in West Africa
Mei Ran Abellona U #35
The establishment of hepatitis B care and treatment clinics in the United Republic of Tanzania: A demonstration project following WHO guidelines
John Rwegasha #44
Session 9: Liver Disease - Public health issues -
Chairs
Ayman Yosry
Cairo University, Egypt
Improving access to treatment in Resource Limited Settings (Not available)
NOhep Visionaries in Africa: Medical professionals leading the way towards hepatitis elimination
Overview
Welcome
Over 150 participants attended the 1st edition of the Conference on Liver Disease in Africa held at Mövenpick Hotel and Residencies, Nairobi, Kenya. We would like to thank everybody for their invaluable contribution in making this workshop such a success.
On behalf of the Organizing Committee, we would also like to express our gratitude to Gilead, Roche and Pharco for their generous support.
Local Chair
Reena Shah, MD
Aga Khan University Hospital, Nairobi
Practical Information
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this conference, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for any applicable insurances. Participants are advised to take out their own insurance policies.
Committees
Organizing Committee
The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They come together on a frequent basis to discuss the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.
Scientific Committee
To augment the organizing committee, the following are scientific committee
members
- Mary Afihene, MBChB, FWACP – Kwame Nkrumah University, Ghana
- Geoffrey Dusheiko, MBBCh, FCP, FRCP - Kings College Hospital, UK
- Alice Guingané, MD, MPH - Hospitalier Universitaire Yalgado Ouedraogo, Burkina Faso
- Emmanuel Musabeyezu, MD, FCP – King Faisal Hospital, Rwanda
- Gibril Ndow, MD – Imperial College London, Gambia
- John Rwegasha, MBChB, M.MED, FRCP, MSc - Muhimbili National Hospital, Tanzania
- Edford Sinkala, MD, PhD - University Teaching Hospital / University of Zambia, Zambia
- Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland
- Christian Tzeuton, MD – Douala Medical School / Société Camerounaise de Gastro-Enterologie, Cameroon
Support
Supporter
Gold Level
Contributor
Endorsers
Endorsers
Language
Related Programs
Sorry… This form is closed to new submissions.